Terminating the pregnancies of female rats on day 16 (D 16) by hysterectomy and ovariectomy (HO) and administering estradiol benzoate (EB) systemically or centrally into the medial preoptic area (MPOA) stimulates the onset of maternal behavior 48 h later. Since estrogen’s effects are mediated through its intracellular receptors, the present studies measured nuclear and cytosol estrogen receptor concentrations in the POA and hypothalamus (HYP) of female rats during the 48 h when estrogen is active in stimulating maternal behavior. A low dose of EB (5 µg/kg) was used which was effective in stimulating maternal behavior in D16HO females but not in nonpregnant HO females of two types. In D16 animals there was a significantly higher concentration of nuclear receptors in the POA than in the HYP at time 0 (before HO and EB) but thereafter levels were similar in the two areas: nuclear receptor levels rose between 6 and 24 h after which they declined. In nonpregnant females, nuclear receptor levels at time 0 were low in both brain regions, rose significantly between 0 and 24 h, and significantly declined between 24 and 48 h similar to the D16 females. There were minimal differences in cytosol receptor levels among all groups at any time. Results from additional groups, nonpregnant HO females given 100 µg/kg EB and D16H animals (females whose pregnancies were terminated by hysterectomy only and their ovaries left intact), both of which exhibit maternal behavior at 48 h, support the idea that a high level of nuclear estrogen receptors in the POA followed by a sustained high level is necessary for estrogen stimulation of maternal behavior.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.